Your browser doesn't support javascript.
loading
A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.
Sawka, Anna M; Ghai, Sangeet; Yoannidis, Tom; Rotstein, Lorne; Gullane, Patrick J; Gilbert, Ralph W; Pasternak, Jesse D; Brown, Dale H; Eskander, Antoine; Almeida, John R de; Irish, Jonathan C; Higgins, Kevin; Enepekides, Danny J; Monteiro, Eric; Banerjee, Avik; Shah, Manish; Gooden, Everton; Zahedi, Afshan; Korman, Mark; Ezzat, Shereen; Jones, Jennifer M; Rac, Valeria E; Tomlinson, George; Stanimirovic, Aleksandra; Gafni, Amiram; Baxter, Nancy N; Goldstein, David P.
Afiliação
  • Sawka AM; Division of Endocrinology, University Health Network and University of Toronto, Toronto, Canada.
  • Ghai S; Joint Department of Medical Imaging, University Health Network-Mt Sinai Hospital-Women's College Hospital, University of Toronto, Toronto, Canada.
  • Yoannidis T; Department of Otolaryngology-Head and Neck Surgery, University Health Network, Toronto, Canada.
  • Rotstein L; Department of Surgery, University Health Network and University of Toronto, Toronto, Canada.
  • Gullane PJ; Department of Otolaryngology-Head and Neck Surgery/Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Canada.
  • Gilbert RW; Department of Otolaryngology-Head and Neck Surgery/Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Canada.
  • Pasternak JD; Department of Surgery, University Health Network and University of Toronto, Toronto, Canada.
  • Brown DH; Department of Otolaryngology-Head and Neck Surgery/Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Canada.
  • Eskander A; Department of Otolaryngology and Head and Neck Surgery, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Canada.
  • Almeida JR; Department of Otolaryngology-Head and Neck Surgery/Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Canada.
  • Irish JC; Department of Otolaryngology-Head and Neck Surgery/Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Canada.
  • Higgins K; Department of Otolaryngology and Head and Neck Surgery, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Canada.
  • Enepekides DJ; Department of Otolaryngology and Head and Neck Surgery, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Canada.
  • Monteiro E; Department of Otolaryngology and Head and Neck Surgery, Mount Sinai Hospital and University of Toronto, Toronto, Canada.
  • Banerjee A; Department of Otolaryngology and Head and Neck Surgery, Grand River Hospital Corporation, Kitchener, Canada.
  • Shah M; Department of Otolaryngology-Head and Neck Surgery/Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Canada.
  • Gooden E; Department of Otolaryngology and Head and Neck Surgery, North York General Hospital and University of Toronto, Toronto, Canada.
  • Zahedi A; Department of Otolaryngology and Head and Neck Surgery, North York General Hospital and University of Toronto, Toronto, Canada.
  • Korman M; Division of Endocrinology, Women's College Hospital, Mount Sinai Hospital and University of Toronto, Toronto, Canada.
  • Ezzat S; Department of Otolaryngology and Head and Neck Surgery, William Osler Health System and University of Toronto, Brampton, Canada.
  • Jones JM; Division of Endocrine Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Rac VE; Department of Psychosocial Oncology, University Health Network and University of Toronto, Toronto, Canada.
  • Tomlinson G; Ted Rogers Centre for Heart Research at Peter Munk Cardiac Centre, Toronto General Hospital Research Institute (TGHRI), University Health Network (UHN), Toronto, Canada.
  • Stanimirovic A; Institute of Health Policy, Management and Evaluation (IHPME), Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Gafni A; Toronto Health Economics and Technology Assessment Collaborative, Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
  • Baxter NN; Department of Medicine University Health Network and Mount Sinai Hospital and Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Goldstein DP; Toronto Health Economics and Technology Assessment Collaborative, Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
Thyroid ; 30(7): 999-1007, 2020 07.
Article em En | MEDLINE | ID: mdl-32126932
Background: Active surveillance (AS) of small, low-risk papillary thyroid cancers (PTCs) is increasingly being considered. There is limited understanding of why individuals with low-risk PTC may choose AS over traditional surgical management. Methods: We present a mixed-methods analysis of a prospective observational real-life decision-making study regarding the choice of thyroidectomy or AS for management of localized, low-risk PTCs <2 cm in maximum diameter (NCT03271892). Patients were provided standardized medical information and were interviewed after making their decision (which dictated disease management). We evaluated patients' levels of decision-self efficacy (confidence in medical decision-making ability) at the time information was presented and their level of decision satisfaction after finalizing their decision (using standardized questionnaires). We asked patients to explain the reason for their choice and qualitatively analyzed the results. Results: We enrolled 74 women and 26 men of mean age 52.4 years, with a mean PTC size of 11.0 mm (interquartile range 9.0, 14.0 mm). Seventy-one patients (71.0% [95% confidence interval 60.9-79.4%]) chose AS over surgery. Ninety-four percent (94/100) of participants independently made their own disease management choice; the rest shared the decision with their physician. Participants had a high baseline level of decision self-efficacy (mean 94.3, standard deviation 9.6 on a 100-point scale). Almost all (98%, 98/100) participants reported high decision satisfaction. Factors reported by patients as influencing their decision included the following: perceived risk of thyroidectomy or the cancer, family considerations, treatment timing in the context of life circumstances, and trust in health care providers. Conclusions: In this Canadian study, ∼7 out of 10 patients with small, low-risk PTC, who were offered the choice of AS or surgery, chose AS. Personal perceptions about cancer or thyroidectomy, contextual factors, family considerations, and trust in health care providers strongly influenced patients' disease management choices.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tireoidectomia / Neoplasias da Glândula Tireoide / Conduta Expectante / Tomada de Decisão Clínica / Câncer Papilífero da Tireoide Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Thyroid Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tireoidectomia / Neoplasias da Glândula Tireoide / Conduta Expectante / Tomada de Decisão Clínica / Câncer Papilífero da Tireoide Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Thyroid Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos